Dr. F. Köhler Chemie GmbH: Clinical Trials

7 trials sponsored by Dr. F. Köhler Chemie GmbH, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 recruiting, 1 suspended. 3 Phase 2, 3 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 23Completed 1, Recruiting 1, Suspended 1
Phase 33Completed 2, Recruiting 1
Phase 41Completed 1

Follow Dr. F. Köhler Chemie GmbH: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Cardioplegia in Cardiac Surgery Due to Congenital Heart Malformation in Children
heart will be treated with Custodiol-N, heart will be treated with Custodiol - Congenital Heart Malformations
Phase 2SuspendedDr. F. Köhler Chemie GmbH1002024-12-052026-02-09
Study of Organ Perfusion in Heart Transplantation in Children
Custodiol-N, Custodiol - Heart Transplantation
Phase 2RecruitingDr. F. Köhler Chemie GmbH152023-08-152026-01-30
Custodiol-N Solution Compared With Custodiol Solution in Organ Transplantation (Kidney, Liver and Pancreas)
Custodiol-N Solution, Custodiol HTK Solution - Kidney Failure, Liver Failure, Chronic
Phase 3RecruitingDr. F. Köhler Chemie GmbH3622019-05-232025-09-10
Study of Organ Perfusion With Custodiol-N Solution Compared With Custodiol Solution in Heart Transplantation
Custodiol-N, Custodiol, organ perfusion for heart transplantation - Heart Failure
Phase 3CompletedDr. F. Köhler Chemie GmbH1052016-07-012020-01-18
Phase III Study Comparing Two Methods of Cardioplegia in Aortic Valve Surgery Custodiol-N Versus Custodiol
Custodiol-N, Custodiol - Aortic Valve Disease, Coronary Artery Disease (CAD)
Phase 3CompletedDr. F. Köhler Chemie GmbH5302014-05-012020-01-18
Phase III Study Comparing Two Methods of Cardioplegia in Coronary Artery Bypass Surgery
Custodiol-N, Custodiol - Coronary Artery Disease (CAD)
Phase 2CompletedDr. F. Köhler Chemie GmbH1022011-03-012013-05-17
Histidine-Tryptophane-Ketoglutarate (HTK) vs University of Wisconsin (UW) Perfusion in Clinical Pancreas Transplantation
Organ perfusion during pancreas procurement - Diabetes Mellitus, Pancreas Transplantation
Phase 4CompletedMedical University Innsbruck682001-07-012008-08-20

Conditions studied

Coronary Artery Disease (2)  ·  Aortic Valve Disease (1)  ·  Diabetes Mellitus (1)  ·  End Stage Liver Disease (1)  ·  Heart Failure (1)  ·  Renal Insufficiency (1)  ·  Reperfusion Injury (1)

Interventions

Custodiol-N solution (6)  ·  Bretschneider cardioplegic solution (1)  ·  Heart Transplantation (1)  ·  Organ Preservation (1)  ·  Solutions (1)  ·  Transplantation (1)

Countries

Germany (6)  ·  Austria (3)  ·  Belgium (1)

Top investigators

Gabor Szabo, Prof. Dr. (2)  ·  Christine-Elena Kamla, Dr. (1)  ·  Christoph Knosalla, Prof. Dr. (1)  ·  Florian Wagner, Dr. (1)  ·  Martin Misfeld, Dr. (1)  ·  Mohamed Salem, Dr. (1)  ·  Nikolaus Pizanis, Dr. (1)  ·  Philippe Grieshaber, PD Dr. (1)  ·  Thorsten Doenst, Prof. Dr. (1)

Results publications

PMID 18954363

NIH funding

2017 (1)